95% of cancer treatments fail during clinical trials, representing a massive inefficiency in drug development
Noetik founders Ron Alfa and Daniel Bear argue the high failure rate stems from a matching problem rather than drug efficacy issues
The company is deploying autoregressive transformers, specifically TARIO-2, to better match patients with appropriate cancer treatments
This AI approach could potentially improve trial success rates by optimizing patient selection and treatment pairing
Ask the AI about this article →
For example, today's edition would include:
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · takes 30 seconds · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. Q&As are published on this page for other readers too.
Israeli startup DataAgent Ltd
SK Hynix presented a custom HBM concept at SEMICON Taiwan 2026, where compute functions are placed in the base…
Nvidia reported earnings that were both remarkable and boring, reflecting its focus on avoiding a consolidated…
Anthropic has agreed to a $35bn cloud-computing contract with Lambda, a Nvidia-backed cloud provider
The Supreme Court of Japan has included about ¥60 million in its fiscal 2027 budget request for AI-related exp…
The Consumer Affairs Agency said Tuesday it will use generative AI to analyze about 900,000 annual consultatio…
